首页> 外文期刊>Dermatology Research and Practice >Indeterminate Cell Histiocytosis in Association with Acute Myeloid Leukemia
【24h】

Indeterminate Cell Histiocytosis in Association with Acute Myeloid Leukemia

机译:不确定的细胞组织细胞增生症与急性髓细胞性白血病相关

获取原文
           

摘要

Indeterminate cell histiocytosis (ICH) is a rare proliferative disorder, in which the predominant cells share morphologic and immunophenotypic features from both Langerhans and non-Langerhans cell histiocytosis. We describe a 62-year-old man presenting a 2-month history of firm nodular lesions on the upper lip. Histopathology, immunohistochemical, and ultrastructural analysis showed typical findings of ICH. The patient was treated with thalidomide and almost complete regression of the lesions was reached within 7 months. Nevertheless, one month after remission, he developed an acute myeloid leukemia of the subtype monocytic leukemia (M5). The patient's condition rapidly worsened and he died due to a respiratory failure four weeks later. We present this case because apart of being rare it joins the effectiveness of thalidomide and the association with an acute monocytic leukemia. A review of the literature is made.
机译:不确定细胞组织细胞增生症(ICH)是一种罕见的增生性疾病,其中主要细胞具有郎格罕氏细胞和非朗格汉斯细胞组织细胞增生症的形态学和免疫表型特征。我们描述了一个62岁的男性,在上唇呈现2个月的牢固结节性病变。组织病理学,免疫组化和超微结构分析显示了ICH的典型发现。该患者接受沙利度胺治疗,在7个月内病灶几乎完全消退。然而,缓解后一个月,他发展为亚型单核细胞白血病(M5)的急性髓细胞性白血病。患者的病情迅速恶化,四周后因呼吸衰竭而死亡。我们提出这种情况是因为除了罕见之外,它还与沙利度胺的疗效以及与急性单核细胞白血病的关联有关。文献综述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号